LoginSignup
DOC

DocMorris

Stock
Stock
ISIN: CH0042615283
Ticker: DOCM
CH0042615283
DOCM

Price

Price

Frequently asked questions

What is DocMorris's market capitalization?

The market capitalization of DocMorris is $493.94M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for DocMorris?

DocMorris's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$9.362. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for DocMorris's stock?

Currently, 12 analysts cover DocMorris's stock, with a consensus target price of $107.80. Analyst ratings provide insights into the stock's expected performance.

What is DocMorris's revenue over the trailing twelve months?

Over the trailing twelve months, DocMorris reported a revenue of $1.13B.

What is the EBITDA for DocMorris?

DocMorris's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$43.98M. EBITDA measures the company's overall financial performance.

What is the free cash flow of DocMorris?

DocMorris has a free cash flow of -$107.45M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of DocMorris's stock?

The 5-year beta for DocMorris is 1.33. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does DocMorris have, and what sector and industry does it belong to?

DocMorris employs approximately 1,453 people. It operates in the Consumer Staples sector, specifically within the Major Drugs industry.

What is the free float of DocMorris's shares?

The free float of DocMorris is 12.12M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $493.94M

5Y beta

 1.33

EPS (TTM)

 -$9.362

Free Float

 12.12M

Revenue (TTM)

 $1.13B

EBITDA (TTM)

 -$43.98M

Free Cashflow (TTM)

 -$107.45M

Pricing

1D span
$33.18$35.10

Analyst Ratings

The price target is $107.80 and the stock is covered by 12 analysts.

Buy

10

Hold

1

Sell

1

Information

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

1,453

Major Drugs

Consumer Staples

Identifier

ISIN

CH0042615283

Primary Ticker

DOCM

Knockouts

Join the conversation
Sign upLogin